Dr. VK Gadi, leads a panel discussion of breast oncologists highlighting their therapy preferences for a woman with HER2-positive metastatic breast cancer previously treated with docetaxel-trastuzumab-pertuzumab followed by paclitaxel and cisplatin.
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive.
View our complete video library.